European Healthcare & Life Sciences Market Update - H1 2022

Welcome to the first edition of our European Healthcare & Life Sciences Market Update, a new report summarising key emerging trends, opportunities, and challenges facing the market in 2022. During the last 12 months, the European healthcare and life sciences market has thrived while in the throes of the Brexit transition and the COVID-19 pandemic and vaccine rollout, showing remarkable growth in M&A and venture capital activity, attracting a fresh crop of global investors, and channeling increased funding into UK digital health.

As new investors approach the market - attracted by the booming biotech and life sciences sector, Europe’s wave of innovation, public and private investment in digital health, and a growing pipeline of pharma carve-outs - dealmakers must stay alert to increasing global regulatory scrutiny. In this edition, amongst myriad regulatory changes faced by the European life sciences industry, we scrutinise the practical implications pharmaceutical companies in Europe and overseas should be aware of now that the EU Clinical Trials Regulation has finally come into effect.

Please see full Report below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Latham & Watkins LLP | Attorney Advertising

Written by:

Latham & Watkins LLP
Contact
more
less

Latham & Watkins LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.